Ftse Mib
35.366,20
0,00%
DAX
18.869,36
0,78%
S&P 500
5.308,15
1,17%
NASDAQ
16.742,39
1,40%
Bitcoin
65.770,00
-0,74%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ EyePoint Pharmaceuticals Inc (EYPT) EyePoint Pharmaceuticals Inc (EYPT) Notizie

EyePoint Pharmaceuticals Inc

EYPT
13,19
0,74 (5,94%)
16 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/5/202416:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202413:05EDGAR2Form 8-K - Current report
08/5/202413:00GLOBEEyePoint Pharmaceuticals Reports First Quarter 2024..
06/5/202415:25EDGAR2Form 8-K - Current report
06/5/202413:00GLOBEEyePoint Pharmaceuticals Announces Topline Data from the..
16/4/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
02/4/202413:00GLOBEEyePoint Pharmaceuticals Expands Scientific Advisory Board..
18/3/202412:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
08/3/202419:53EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202413:05EDGAR2Form 8-K - Current report
07/3/202413:00GLOBEEyePoint Pharmaceuticals Reports Fourth Quarter and..
04/3/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:37EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/3/202413:01EDGAR2Form 8-K - Current report
04/3/202413:00GLOBEEyePoint Pharmaceuticals Announces Appointment of Ramiro..
29/2/202413:00GLOBEEyePoint Pharmaceuticals to Report Fourth Quarter and..
27/2/202413:00GLOBEEyePoint Pharmaceuticals Announces Participation at Upcoming..
22/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
15/2/202403:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202422:20GLOBEEyePoint Pharmaceuticals Announces Two Presentations of..
02/2/202422:22EDGAR2Form 144 - Report of proposed sale of securities
31/1/202413:00GLOBEEyePoint Pharmaceuticals to Present at the Guggenheim..
30/1/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:25EDGAR2Form 144 - Report of proposed sale of securities
24/1/202422:17EDGAR2Form 144 - Report of proposed sale of securities
23/1/202422:42EDGAR2Form 144 - Report of proposed sale of securities
23/1/202422:19EDGAR2Form 144 - Report of proposed sale of securities
22/1/202422:19EDGAR2Form 144 - Report of proposed sale of securities
17/1/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
11/1/202423:33EDGAR2Form 144 - Report of proposed sale of securities
11/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202413:05EDGAR2Form 8-K - Current report
Apertura: 12,71 Min: 12,68 Max: 13,42
Chiusura: 12,45

La tua Cronologia

NASDAQ
EYPT
EyePoint Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network